The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
It’s time to revamp the FDA’s “generally recognized as safe,” or GRAS, program that allows companies to add untested ...
In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...
A new study from researchers at Boston University found microplastics may play a role in the spread of drug-resistant ...
Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...
There's rosemary, that's for remembrance,' says Ophelia in Shakespeare's Hamlet. So it is fitting that researchers would study a compound found in rosemary and sage -- carnosic acid -- for its impact ...
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...
The United States was the major funder of tuberculosis programs. Now hundreds of thousands of sick patients can’t find tests ...
Ropar: Punjab health minister Dr Balbir Singh on Monday visited a local de-addiction centre to assess healthcare services and ...
Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...
Indoco Remedies declined 3.22% to Rs 224.20 after its Clinical Research Organization, AnaCipher, located in Hyderabad, received one Form 483 from the United States Food and Drug Administration (US FDA ...